PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsLeucovorin
Leucovorin
Leucovorin (leucovorin) is a small molecule pharmaceutical. Leucovorin was first approved as Leucovorin calcium on 1982-01-01. It is used to treat folic acid deficiency and megaloblastic anemia in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
hemic and lymphatic diseasesD006425
nutritional and metabolic diseasesD009750
Trade Name
FDA
EMA
Leucovorin (discontinued: Leucovorin, Wellcovorin)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Leucovorin calcium
Tradename
Company
Number
Date
Products
WELLCOVORINGSKN-018342 DISCN1983-07-08
2 products, RLD
LEUCOVORIN CALCIUMHospiraN-008107 DISCN1982-01-01
5 products, RLD
LEUCOVORIN CALCIUMXanodyne PharmaceuticalsN-018459 DISCN1986-01-30
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
enbrace hrunapproved drug other2025-01-02
enlyteunapproved drug other2022-07-01
leucovorinANDA2014-09-26
leucovorin calciumANDA2025-09-29
paxlyteunapproved drug other2024-12-19
pyrimethamine leucovorinunapproved drug other2015-11-30
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
V03: All other therapeutic products
V03A: All other therapeutic products
V03AF: Detoxifying agents for antineoplastic treatment
V03AF03: Calcium folinate
HCPCS
Code
Description
J0640
Injection, leucovorin calcium, per 50 mg
J0641
Injection, levoleucovorin, not otherwise specified, 0.5 mg
J0642
Injection, levoleucovorin (khapzory), 0.5 mg
Clinical
Clinical Trials
3182 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Colorectal neoplasmsD0151791444232071235745
Pancreatic neoplasmsD010190EFO_0003860C259519043119300
NeoplasmsD009369C801351124829276
Rectal neoplasmsD0120045015666114267
Colonic neoplasmsD003110C185310472115217
Stomach neoplasmsD013274EFO_0003897C163313741215208
AdenocarcinomaD0002304614232110205
Neoplasm metastasisD009362EFO_000970838843116149
Liver neoplasmsD008113EFO_1001513C22.0125931119115
LymphomaD008223C85.91849181783
Show 121 more
Indications Phases 3
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients921526
Endometrial neoplasmsD016889EFO_0004230121116
Myeloid leukemia acuteD015470C92.013415
Triple negative breast neoplasmsD06472611815
Cognitive dysfunctionD060825G31.84131014
Squamous cell carcinoma of head and neckD0000771956912
Mantle-cell lymphomaD020522C83.14711
Appendiceal neoplasmsD001063EFO_0003880C18.164111
AgingD000375GO_0007568R41.812911
Hodgkin diseaseD006689C817510
Show 165 more
Indications Phases 1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Gyrate atrophyD0157991212
Breast feedingD00194288
AvitaminosisD001361EFO_0005878E56.977
AlopeciaD000505L6455
Healthy dietD00007200155
Feeding behaviorD00524755
Diet therapyD00403544
Child developmentD00265744
Nutritional statusD00975244
Postoperative cognitive complicationsD00007969044
Show 205 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameLeucovorin
INNcalcium folinate
Description
Folinic acid, also known as leucovorin, is a medication used to decrease the toxic effects of methotrexate and pyrimethamine. It is also used in combination with 5-fluorouracil to treat colorectal cancer and pancreatic cancer, may be used to treat folate deficiency that results in anemia, and methanol poisoning. It is taken by mouth, injection into a muscle, or injection into a vein.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O
Identifiers
PDB
CAS-ID58-05-9
RxCUI
ChEMBL IDCHEMBL1679
ChEBI ID15640
PubChem CID6006
DrugBankDB03256
UNII IDRPR1R4C0P4 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Leucovorin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 39,579 documents
View more details
Safety
Black-box Warning
Black-box warning for: Enlyte
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
45,408 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use